Antiepileptic drug development: II. Anticonvulsant drug screening.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000633:toxicity; D002490:Central Nervous System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods* / Q000592:standards; D004345:Drug Industry; D004597:Electroshock; D008297:Male; D051379:Mice; D009048:Motor Skills / Q000187:drug effects; D010433:Pentylenetetrazole; D011786:Quality Control; D012107:Research Design; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology
D000927:Anticonvulsants; D010433:Pentylenetetrazole